Výsledky vyhledávání - "J L, Aguilar Ponce"

Abstract P1-11-14: Efficacy and quality of life analysis of palonosetron vs ondansetron for high and moderate emetogenic chemotherapy for breast cancer

Autor: J Santamaría-Galicia, Nancy Reynoso-Noverón, O Macedo, J. L. Aguilar-Ponce, Juan Matus-Santos, Claudia Arce-Salinas, D. Flores-Díaz, JP Gonzalez-Serrano, Z Deneken-Hernandez, Erika Ruiz-García, G Calderillo-Ruiz

Publikováno v: Cancer Research. 79:P1-11

Background: Nausea and vomiting are common complications on the chemotherapy (CINV) and can affect the quality of life of the patients. There are various antiemetic regiments that varies in both cost and effectiveness. The aim of this trial is to eva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fba3c02ea67c961623f895f9d921e29e
https://doi.org/10.1158/1538-7445.sabcs18-p1-11-14

Zobrazit plný text záznamu

Deterioration of nutritional status of patients with locally advanced cervical cancer during treatment with concomitant chemoradiotherapy

Autor: J. L. Aguilar‐Ponce, J. Luvián-Morales, L. Cetina, R. Jiménez-Lima, M. Sánchez, D. Isla‐Ortiz, Denisse Castro-Eguiluz

Publikováno v: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association. 32(4)

Background In Mexico, 80% women with cervical cancer are diagnosed at locally advanced stages and are treated with concomitant chemoradiotherapy. The treatment modality and catabolic state confer a nutritional risk. The present study aimed to thoroug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40129ae79e744164fd95e88f0852c189
https://pubmed.ncbi.nlm.nih.gov/30938007

Zobrazit plný text záznamu

Overweight and obesity as poor prognostic factors in locally advanced breast cancer patients

Autor: D. Flores-Díaz, A. Alvarado Miranda, D. Olvera-Caraza, Claudia Arce-Salinas, Alejandro Mohar, Fernando Lara-Medina, Cynthia Villarreal-Garza, J. L. Aguilar-Ponce

Publikováno v: Breast cancer research and treatment. 146(1)

Obesity and overweight are established risk factors for the development of breast cancer. They are also associated with poor prognosis for higher risk of disease recurrence and lower overall survival (OS). The aim of this study was to evaluate the in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1449d24a97ef9fb3ade9c32c6ab03e84
https://pubmed.ncbi.nlm.nih.gov/24842266

Zobrazit plný text záznamu

Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck

Autor: B. Segura-Pacheco, D. Green, Alfonso Dueñas-González, A. Poitevin-Chacon, Ángel Herrera-Gómez, A. Alvarado, J.-L. Aguilar-Ponce, Kuauhyama Luna-Ortiz, Martín Granados-García, V V Villavicencio, J. de la Garza, Héctor Martínez-Said, C. Castillo-Henkel

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 15(2)

Concurrent chemoradiation is the current standard of treatment for patients with advanced unresectable head and neck squamous cell carcinoma (HNSCC). Due to the potent radiosensitizing properties of gemcitabine, we decided to assess its efficacy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a25b84d9b568bec7a3efa3361233d2
https://pubmed.ncbi.nlm.nih.gov/14760126

Zobrazit plný text záznamu

Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: therapeutic and pharmacoeconomic perspectives

Autor: J L, Aguilar Ponce, Y, Flores-Picazo, J, Pérez-Urizar, G, Castañeda-Hernández, J W, Zinser-Sierra, A, Dueñas-González, E, Calderón-Flores, B A, Segura-Pacheco, J, de la Garza-Salazar

Publikováno v: Archives of medical research. 30(3)

Oral etoposide administration is a suitable alternative to the intravenous route; therefore, commercial capsules have been developed. Before these capsules were available in Mexico, we studied drug bioavailability after oral administration of the int

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b054a5371405dd78a55598dab8603667
https://pubmed.ncbi.nlm.nih.gov/10427872

Zobrazit plný text záznamu

Phase II open, single-arm trial: Cisplatin combined with paclitaxel and doxorubicin in operable or locally advanced triple-negative breast cancer

Autor: N. Castañeda-Soto, C. Cano Blanco, Claudia Arce, A. Alvarado Miranda, J. L. Aguilar Ponce, F. U. Lara Medina, Víctor Pérez-Sánchez, E. Bargallo Rocha

Publikováno v: Journal of Clinical Oncology. 29:1135-1135

1135 Background: Cisplatin has shown antitumor activity in breast cancer, and shows synergy with paclitaxel and antitumor activity in anthracycline-resistant breast tumors. In triple negative tumor...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::80f6387896e7ac8a6c2a84e0df4cf9bc
https://doi.org/10.1200/jco.2011.29.15_suppl.1135

Zobrazit plný text záznamu

Isolated limb perfusion with high-dose ifosfamide in the treatment of locally advanced sarcoma. A pilot study

Autor: Paula Cabrera, M. Cuellar, G. Rico, J.-L. Aguilar-Ponce, J. de la Garza, P. Alejandro, Carlos Lopez-Graniel, Héctor Martínez-Said

Publikováno v: Journal of Clinical Oncology. 23:9053-9053

9053 Background: Recent studies have evaluated the role of isolated limb perfusion (ILP) and hyperthermia in the management of extremity sarcoma. The agents most commonly employed for ILP have been...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::157ed28d848da1c0e83a2b1e4a276931
https://doi.org/10.1200/jco.2005.23.16_suppl.9053

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání